Skip to main content

Peer Review reports

From: Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial

Original Submission
2 Dec 2021 Submitted Original manuscript
20 Jan 2022 Reviewed Reviewer Report
30 Jul 2022 Reviewed Reviewer Report - Carlotta Lunghi
16 Aug 2022 Author responded Author comments - Mohammadreza Shalbafan
Resubmission - Version 2
16 Aug 2022 Submitted Manuscript version 2
23 Aug 2022 Author responded Author comments - Mohammadreza Shalbafan
Resubmission - Version 3
23 Aug 2022 Submitted Manuscript version 3
27 Aug 2022 Reviewed Reviewer Report - Carlotta Lunghi
1 Sep 2022 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Sep 2022 Editorially accepted
27 Sep 2022 Article published 10.1186/s40360-022-00610-5

You can find further information about peer review here.

Back to article page